SEC 13F Intelligence

Pggm Investments / ALXN

Pggm Investments’s Alexion Pharmaceuticals Inc Position

Does Pggm Investments own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 90.8K shares worth $14M in Q1 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$14M
Q1 2021
Shares
90.8K
% of Portfolio
+0.06%
Quarters Held
4
position exited

Position History ALXN

Reported value by quarter
Q2 ’20: $37MQ2 ’20Q3 ’20: $49MQ3 ’20Q4 ’20: $28MQ4 ’20Q1 ’21: $14MQ1 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202190.8K$14M+0.06%
Q4 2020178.9K$28M+0.13%
Q3 2020426.2K$49M+0.25%
Q2 2020327.2K$37M+0.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Pggm Investments’s full portfolio or all institutional holders of ALXN.